20-62260001-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The ENST00000313733.9(OSBPL2):āc.58T>Cā(p.Ser20Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000313733.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSBPL2 | NM_144498.4 | c.58T>C | p.Ser20Pro | missense_variant | 3/14 | ENST00000313733.9 | NP_653081.1 | |
OSBPL2 | NM_001363878.2 | c.-309T>C | 5_prime_UTR_variant | 3/15 | NP_001350807.1 | |||
OSBPL2 | NM_001278649.3 | c.-184-3615T>C | intron_variant | NP_001265578.1 | ||||
OSBPL2 | NM_014835.5 | c.38-16T>C | splice_polypyrimidine_tract_variant, intron_variant | NP_055650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSBPL2 | ENST00000313733.9 | c.58T>C | p.Ser20Pro | missense_variant | 3/14 | 1 | NM_144498.4 | ENSP00000316649 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251370Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135870
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461768Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727192
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74302
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 02, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at